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ANALYSIS OF IN VIVO TISSUE EXPANDER FLUID COMPOSITION. 
Richard A. Nahouraii (Sponsored by Richard J. Restifo). Department of Plastic 
Surgery, Yale University, School of Medicine, New Haven, CT. 
The ability of the electrolytes of normal saline to diffuse through tissue expanders 
implanted in rats was examined. Eleven Sprague-Dawley rats were each implanted 
with one smooth shelled 20 mL tissue expander filled with normal saline. At intervals 
of 6, 7, 8, 9, and 12 weeks post-implantation, animals were sacrificed and the saline 
within the expanders was analyzed by potentiometric ion analysis for the concentrations 
of sodium, chloride, potassium, and bicarbonate; the osmolarities of the solutions were 
also determined. A similar analysis was performed for three control samples of normal 
saline. The results are shown below: 
mean [Na+] 
(mEq/L) 
mean [K+] 
(mEq/L) 
mean [CL] 
(mEq/L) 
mean [HC03 ] 
(mEq/L) 
mean 
Osmolarity 
control saline 145.80 0.00350 181.68 0.19 327.48 
SEM 0.67 0.0002 1.50 0.02 1.64 
expander saline 145.55 0.0116 180.10 0.51 325.66 
SEM 0.33 0.00010 2.11 0.01 2.44 
A linear correlation analysis of the individual electrolyte concentrations in each 
expander was performed to determine their relationship with time of implantation. No 
statistically significant correlation was observed at the p = 0.05 level of significance 
(two-tailed). 
In light of the absence of a temporal relationship, the mean electrolyte concentrations 
among all the expanders were compared against the mean electrolyte concentrations in 
the controls using a Cochran t-test. The t-test indicated no statistically significant 
differences between the mean sodium and chloride concentrations from the expanders 
and those of the controls at the p=0.05 level. The differences between the mean 
potassium and bicarbonate concentrations from the expanders and controls were found 
to be statistically significant at the p=0.05 level. These differences, however, could be 
accounted for by contamination of the expander saline with interstitial fluid during 
inflation. We conclude that no significant changes in the average concentrations of the 
major electrolytes of saline within tissue expanders were observed in vivo. 
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Introduction 
In 1964, the first augmentation mammaplasty using a silicone gel implant was 
reported[l]. By 1991, an estimated two million women had received silicone gel breast 
implants for cosmetic augmentation mammaplasty or postmastectomy breast 
reconstruction^] with an overall satisfaction rate exceeding 90%, according to a 1990 
survey by the American Society of Plastic and Reconstructive Surgeons[3]. The 
popularity of breast augmentation, particularly with silicone gel as opposed to saline 
filled implants, had grown considerably during the 1980s. So too, however, had 
reports associating connective tissue disorders with silicone gel implants. Although a 
few lawsuits alleging personal injury had appeared in the 1980s, the number of such 
lawsuits increased as the news media began to question the safety of implants. With 
the controversy escalating, the FDA began a review of the silicone gel breast implant, 
which, being a medical device marketed prior to 1976, was exempt from the Medical 
Device Amendment to the Federal Food, Drug, and Cosmetics Act requiring evidence 
of product safety and efficacy prior to the sale of new devices. In 1992, the 
commissioner of the FDA, David A. Kessler, requested a voluntary moratorium on the 
use of silicone gel breast implants pending further evaluation by the FDA General and 
Plastic Surgery Devices Panel. Although the moratorium was lifted the following June, 
and a schedule and guidelines for resuming the use of silicone gel breast implants 
through controlled studies were created, the fear and publicity which ensued generated 
a barrage of litigation, ultimately resulting in a $4.25 billion dollar class-action 
settlement that both destroyed the Dow Corning Corporation and effectively terminated 
the use of silicone gel breast implants. 
The debate surrounding the safety of such implants continues today, despite the 
publication of several large, well designed epidemiological studies that found no 
association between implants and connective tissue diseases[4, 5,6]. Although the 
scientific, legal, and social consequences of this debate are legion, one outcome is for 
certain: the FDA, the public, and the courts will demand a more detailed 
characterization of the properties and behavior of all medical devices, both in vitro and 
in vivo. In particular, any device containing silicone, especially one used in cosmetic 
and reconstructive procedures, is subject to intense scrutiny and may be a target of 
future litigation. 
Because silicone shelled saline implants remain the only prostheses available for breast 
augmentation, and a closely related product, the silicone shelled tissue expander, is 
widely used in reconstructive procedures, the further characterization of all aspects of 
these devices is crucial. Like silicone gel implants, saline implants and expanders 
contain polydimethylsiloxane (PDMS), a polymer of carbon (in the form of methyl 
groups) attached to silicon atoms in siloxane linkages with a general formula of [— 
Si(CH3)2—0--] [1, 7], Unlike gel implants, however, saline implants and expanders do 
not contain silicone in its gel form. Rather, they contain a hard external shell of 
silicone elastomer which is identical to the external silicone shell of a gel implant. 
Elastomeric silicone achieves its hardness by several chemical modifications to the 
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standard PDMS architecture. Specifically, methyl groups are replaced with vinyl, 
hexenyl, trifluoropropyl, and phenyl groups, all of which may be cross-linked to 
increase shell hardness and decrease (but not entirely eliminate) the shell's 
permeability. Also, a considerable amount of fumed silica (silica oxide) is added to the 
shell to further strengthen it[l, 7]. 
That the elastomeric silicone shell of gel implants is not impermeable was first noted 
anecdotally by Dow Corning sales people, who reported that silicone "bled" through 
the shell in demonstration models used for presentations[3]. Later, studies by Barker et 
al. and Thomsen et al. confirmed that such bleeding occurs in vivo[8, 9]. 
Furthermore, researchers since the late 1970s have examined the permeability of the 
shells of saline implants and tissue expanders. Austad and Rose established that water 
could be driven into an expander by creating a large osmotic gradient across the 
expander wall with sodium chloride, thus making the implant interior hypertonic 
relative to extracellular water; they called their device a self-inflating tissue 
expander[10]. Their experiments, done largely in vitro, employed identical silicone 
shelled implants which were filled with varying amounts of solid sodium chloride and 
immersed in sterile saline baths maintained at physiological temperature. They 
observed a direct relation between intraluminal sodium chloride concentration at 
maximal inflation and both the rate and extent of expansion. In particular, they noted 
that inflation to maximal volume (180 mL) was contingent upon an amount of sodium 
chloride sufficient to render the contents of the implant not only hypertonic relative to 
the surrounding fluid but also fully saturated with sodium chloride at maximal inflation. 
Implants with lesser amounts of sodium chloride initially matched the rate of expansion 
of their fully saturated counterparts but would inevitably become unsaturated, at which 
point the expansion rate decreased dramatically and maximal volume never achieved. 
Significantly, implants containing only enough sodium chloride to make them isotonic 
at full inflation had the slowest rates of expansion, effectively ceasing to expand past a 
volume of less than 30 mL. 
Other groups, prompted by efforts to control infection and capsular contracture, 
injected antibiotics along with saline filler into expanders and studied the diffusion of 
these agents across the expander wall using both in vitro and in vivo experimental 
models [11, 12, 13, 14], Early studies, such as the work of Burkhardt et al.[11], 
demonstrated the ability of intraluminal antibiotics to diffuse through a silicone shell, at 
least in vitro; claims of in vivo activity and a subsequent biological effect were clouded 
by poor experimental design and thus extensively criticized[15]. Birnbaum et al. 
demonstrated the ability of povidone-iodine filled implants to induce zones of inhibition 
on bacterial laden agar plates and, through quantitative analysis, proved that free iodine 
(b) was diffusing out, leaving the iodide fraction behind[14]. More recently, Kenna et 
al. employed an in vitro model consisting of antibiotic filled tissue expanders 
submerged in standard volumes of dilute fresh frozen plasma which were subsequently 
inoculated with S. aureus or S. epidermidis. Their findings of inhibited bacterial 
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growth in the medium external to the antibiotic filled implants confirmed the ability of 
antibiotics to diffuse across a silicone membrane[13]. 
Antibiotics, however, have not been the sole focus of implant diffusion studies. Early 
on, studies examined the use of soluble steroids within implants[16, 17, 18]. Recent 
work by Berman's group employed UV spectroscopy to quantify steroid, steroid 
breakdown products, and the benzyl alcohol diluent in methylprednisolone filled tissue 
expanders submerged in saline baths. His group used similar techniques in a separate 
set of experiments to evaluate lidocaine diffusion across implants, both in vitro and in 
vivo. They found an extremely slow rate of steroid diffusion across the expander wall 
and a very high rate of benzyl alcohol diffusion, raising questions concerning the 
effectiveness of steroid laden implants in preventing capsular contracture[19], The 
lidocaine experiments demonstrated mean in vitro and in vivo diffusion rates of 1.8% 
and 3% per day, respectively, with wall thickness being the primary determinant of 
diffusion rate[20]. 
The ultimate goal of these and other experiments is a deeper understanding of the 
factors influencing the diffusion of molecules across implants and tissue expanders. 
Such knowledge will, at the very least, help the scientific community address future 
questions and/or disputes pertaining to the behavior of saline expanders and implants in 
vivo. More exciting, however, is the possibility that as the role of molecular size, 
hydrophobicity/hydrophilicity, and charge are revealed and compared with the 
influence of wall thickness and possible interactions with silicone elastomer, it will 
become possible to employ tissue expanders and implants as drug delivery systems in a 
safe and effective manner. An immediate application would be along the lines of 
Berman's research with lidocaine, the obvious goal being the amelioration of the 
significant pain associated with expansion. Another possibility might be the 
intraluminal placement of tamoxifen or the newer steroidal anti-estrogens in saline 
implants or expanders, perhaps allowing a sustained, local release of these drugs in 
postmastectomy breast reconstruction patients. Obviously, a better understanding of 
the behavior of expanders and implants in vivo will help toward such goals. Our study 
is an attempt to advance the current state of knowledge of the in vivo behavior of 
implants and expanders. The purpose of this study is to assess possible changes in vivo 
in the electrolyte composition of saline used within expanders by quantifying, over 
time, the electrolytes sodium, potassium, chloride, and bicarbonate in tissue expanders 
implanted in rats. No group, to our knowledge, has evaluated the possibility of 
changes in vivo in the composition of saline within silicone-shelled implants or 
expanders. We hypothesize that, given the impermeability of silicone to ions and the 
isotonicity of the intraluminal saline, no significant change in the average 
concentrations of the major ionic constituents of saline over the duration of the 
experiment will occur. 

Methods 
Eleven male albino Sprague-Dawley rats weighing 350 to 400 gm were used. Yale 
Animal Care and Use Committee guidelines for the care and use of laboratory animals 
were followed. Intraperitoneal pentobarbital (30 mg/kg) was used for anesthesia with 
supplemental doses of 5 to 10 mg/kg given as needed. Prior to the procedure, the rats 
were shaved dorsally, a commercial depilatory was applied, and the animals were 
marked for follow up with indelible marker. The animals were prepared with 
povidone-iodine and draped. A dorsal paramedian incision was made and a 
subcutaneous pocket created with hemostasis attained by sterile, disposable cautery 
units. 
The tissue expanders used in this study were sterile, smooth shelled 20 mL saline 
implants with integral injection ports (McGhan Medical Corp, Santa Barbara, CA) 
(Figure 1). Using a 23-gauge needle, each expander was filled with 10 mL of sterile 
normal saline (Abbott Laboratories, North Chicago, IL). The expander was then 
inserted into the subcutaneous pocket of the animal, with the injection port positioned 
dorsally. After securing the expander within the pocket by partially closing the skin 
incision with interrupted 4-0 nylon, 10 more milliliters of saline were injected, filling 
the expander to a total volume of 20 mL. The skin incision was then completely 
closed. The animals were monitored post-operatively and after suitable recovery were 
transferred to the Animal Care Center. The final appearance of an implanted rat after 
wound healing is shown in Figure 2. 
At intervals of 6, 7, 8, 9, and 12 weeks post-implantation, animals were sacrificed and 
the expanders removed (Figure 3). After cleaning the external surface of each 
expander with 70% isopropanol and allowing it to evaporate to dryness, the implant 
contents were withdrawn with a 23-gauge needle into marked, sterile 20 mL syringes. 
The samples, along with three control samples of normal saline, were sent for ion 
analysis to a commercial laboratory (Baron Consulting, Milford, CT). Concentrations 
of sodium, potassium, chloride, and bicarbonate were determined for each sample. 
Sodium and potassium concentrations were determined with the samples run as 
received on a Perkin Elmer 3030AA potentiometer. Chloride concentrations were 
determined by potentiometric titration with silver nitrate using a Metrohm 665 Dosimat 
Titrator and Metrohm 686 Titroprocessor. Bicarbonate concentrations were 
determined by CO2 evolution with 2N HCIO4 using a Coulometrics' Carbonate Carbon 
Apparatus. 
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Results 
Gross observation of the expanders at the time of their removal revealed no damage to 
the expanders. No variations in volume recovery occurred; the original 20 mL placed 
in each sample was fully recovered. Manual pressure applied to the expanders revealed 
no evidence of punctures or other compromises of the expander walls. The formation 
of a fibrous capsule around the expanders was observed in each animal (Figure 4). No 
hematomas were found. Capsular infection was observed in only one specimen 
(sample 2, implanted 44 days). 
The results of the quantitative analysis for each sample, along with the means, standard 
deviations, and standard error of the means, are shown in Table 1. The results for the 
analysis of the control saline (three trials; Cl, C2, and C3) are shown in Table 2. 
Table 3 contains the mean electrolyte concentrations for each time point used in the 
correlation analysis described below. Finally, Table 4 shows the average values and 
standard deviations of the relevant electrolytes in normal male albino rats, and Table 5 
compares the average electrolyte concentrations and osmolarities among the expanders, 
the controls, and rat plasma. A pair of graphs was generated for the electrolytes 
measured in each expander (Graphs 1 through 4). The upper graph of each pair depicts 
the concentrations of the electrolyte in question in the saline of the expanders, which 
are arranged on the x-axis in descending order of time implanted. The lower graph, 
arranged in a similar fashion, depicts the difference between the electrolyte 
concentration in the saline of each expander and the mean electrolyte concentration of 
the controls. In addition to these graphs, another set of graphs (Graphs 5 and 6) was 
created to better show the change in the electrolyte concentrations with time. For 
expanders with equal durations of implantation, the average concentrations of their 
electrolytes were computed and assigned to the time points in question. This data is 
contained in Table 3 and constitutes the data points for Graphs 5 and 6; it also was 
used for the correlation analysis shown below. Both sets of graphs may be inspected 
visually for trends. Given the relatively short observation period of this study, the 
overall appearance of the graphs, and the constraints of mathematical simplicity, a 
linear correlation analysis was employed to examine the correlation between the 
electrolyte concentrations and osmolarities of the implanted expanders and the duration 
of their implantation. The results are as follows: 
Sodium Potassium Chloride Bicarbonate Osmolarity 
r2 0.0033 0.30 0.0021 0.41 0.0076 
r 0.057 0.55 0.045 0.64 0.087 
t5 0.13 1.47 0.10 1.87 0.20 
t(0.05,5,2) 2.57 
where 
r = S (Xj - X)(Yj - Y) / (Z (Xj - X)2)1/2 (I (Yl - Y)2)1/2 [X=time, Y=concentration] 
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t5 = test statistic for 5 degrees of freedom = r / ((1 - r2) / 5)1/2 
t(0.05,5,2) = critical t value at 0.05 level of significance (two-tailed) with 5 d.o.f. 
The decision rule, using a 0.05 level of significance, is to reject the null hypothesis 
(i.e., H0 = no correlation) if t5 >t(0.Q5,5,2) or if t5 < -t(0.05,5,2). By this criteria, 
neither the electrolytes nor the osmolarities show a statistically significant correlation 
with time. 
The lack of any statistically significant correlation between time of implantation and 
electrolyte concentrations or osmolarities argues against a temporal relationship among 
these variables. This argument is further buttressed by the short observation period of 
the experiment and the overall appearance of the graphs. In light of these facts, the 
data were pooled and the mean concentrations of the electrolytes from the expanders 
were compared against the mean concentrations from the controls. Cochran t-tests[21] 
for the difference between the expander saline mean concentrations and the control 
saline mean concentrations were performed for each electrolyte. Unlike the standard t 
test, the Cochran test does not assume equality of variances in the two groups being 
tested. Although it could be argued that the two groups of saline (expanders versus 
controls) should be expected to have the same variances, such an argument assumes 
either no change in the composition of the expanders or changes in which the mean 
may be altered but the dispersion of the individual values about that mean (i.e. the sum 
of the squares of their deviations) remains the same. Not assuming equal variances has 
the effect of establishing a more stringent criteria for accepting the hypothesis of no 
change. Results of the analysis, including the test statistic t' and the Cochran critical 
value of t at the 0.05 level of significance (two-tailed) are shown in the table below, 
with formulas for the Cochran test statistic following. 
Sodium Potassium Chloride Bicarbonate Osmolarity 
Wl 5.00 6.83E-07 24.64 5.32E-03 29.54 
W2 0.34 2.91E-08 13.37 4.48E-04 17.79 
11(0.05,10,2) 2.23 2.23 2.23 2.23 2.23 
12(0.05,2,2) 4.30 4.30 4.30 4.30 4.30 
Cochran t 2.36 2.31 2.96 2.39 3.01 
t' -0.11 9.61 -0.26 4.30 -0.26 
where 
t' = ( mea^ - mean2) / ( Sj2 / nj +S22 / n2 )1/2 
Wj= Sj2/ nj and W2 = S22 / n2 (S = standard deviation of sample) 
tj = critical t value at 0.05 level of significance (two-tailed) with 10 d.o.f. 
U = critical t value at 0.05 level of significance (two-tailed) with 2 d.o.f. 
Cochran t = (t,W, + t2W2 ) / ( W, +W2 ) 
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The decision rule, using a 0.05 level of significance, is to reject the null hypothesis 
(i.e., H() = equal means) if t' > Cochran t or if t' < - (Cochran t). The differences 
were statistically significant for potassium and bicarbonate; sodium, chloride, and 
osmolarity showed no statistically significant difference between the sample and control 
means. 
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Sample Days implanted Na + 
(mEq/L) 
K + 
(mEq/L) 
Cl- 
(mEq/L) 
HC03- 
(mEq/L) 
Osmolarity 
0 81 143.91 0.0179 190.17 0.76 334.08 
1 61 161.30 0.0069 162.14 0.87 323.45 
2 44 150.87 0.0105 199.35 0.02 350.22 
3 54 132.17 0.0100 192.93 0.78 325.10 
4 49 145.65 0.0115 173.80 0.49 319.45 
5 49 147.83 0.0110 178.14 0.38 325.97 
6 49 148.70 0.0120 203.75 0.27 352.44 
7 48 145.87 0.0107 186.45 0.57 332.32 
8 48 139.35 0.0105 154.56 0.48 293.91 
9 47 139.35 0.0141 158.76 0.48 298.11 
10 47 146.09 0.0125 181.07 0.55 327.16 
mean 145.55 0.0116 180.10 0.51 325.66 
stdev 7.42 0.0027 16.46 0.24 18.02 
N 11 11 11 11 11 
SEM 0.67 0.0002 1.50 0.02 1.64 
Table 1. Quantitative analysis of saline from eleven expanders. Saline osmolarity is 
calculated as [Na+] + [Cl]. 
Sample Na + 
(mEq/L) 
K + 
(mEq/L) 
Cl- 
(mEq/L) 
HC03- 
(mEq/L) 
Osmolarity 
Cl 146.96 0.00332 188.73 0.18 335.69 
C2 145.22 0.00332 179.83 0.23 325.05 
C3 145.22 0.00384 176.48 0.15 321.70 
mean 145.80 0.00350 181.68 0.19 327.48 
stdev 1.00 0.00030 6.33 0.04 7.31 
N 3 3 3 3 3 
SEM 0.33 0.00010 2.11 0.01 2.44 
Table 2. Quantitative analysis of saline from three controls. Saline osmolarity is 
calculated as [Na+] + [Cl ]. 
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Sample Days 
implanted 
Na + 
(mEq/L) 
K + 
(mEq/L) 
Cl- 
(mEq/L) 
HC03- 
(mEq/L) 
Osmolarity 
0 81 143.91 0.0179 190.17 0.76 334.08 
1 61 161.30 0.0069 162.14 0.87 323.45 
2 44 150.87 0.0105 199.35 0.02 350.22 
3 54 132.17 0.0100 192.93 0.78 325.10 
4,5,6 49 147.39 0.0115 185.23 0.38 332.62 
7,8 48 142.61 0.0106 170.51 0.52 313.12 
9,10 47 142.72 0.0133 169.92 0.52 312.63 
Table 3. Average electrolyte concentrations and osmolarities for correlation analysis. 
Na + 
(mEq/L) 
K + 
(mEq/L) 
Cl- 
(mEq/L) 
HC03- 
(mEq/L) 
BUN 
(mg/dL) 
glucose 
(mg/dL) 
mean 147 5.82 102 24.0 15.5 78 
stdev 2.65 0.11 0.85 3.80 4.44 14 
Table 4. Electrolyte values in plasma of the normal male albino rat[22]. 
Na+ 
(mEq/L) 
K + 
(mEq/L) 
Cl- 
(mEq/L) 
HC03- 
(mEq/L) 
Osmolarity BUN 
(mg/dL) 
glucose 
(mg/dL) 
control saline 145.80 0.00350 181.68 0.19 327.48 
expander saline 145.55 0.0116 180.10 0.51 325.66 
rat plasma 147.00 5.82 102.00 24 303.87 15.5 78 
Table 5. Comparison of mean electrolyte concentrations in expander saline, control 
saline, and rat plasma. Plasma osmolarity is calculated as 2[Na+] 
+ BUN/2.8 + glucose/18. 
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Discussion 
This experiment evaluated the possibility of changes in vivo in the composition of 
saline within silicone-shelled tissue expanders. Overall, the findings appear to support 
the initial hypothesis of no significant changes in the average concentrations of the 
electrolytes of the expander saline. The data indicate that the mean sodium and 
chloride concentrations and the mean osmolarity, over all expanders over the entire 
range of implantation periods, did not differ significantly from the normal saline 
controls. The volumes of the expanders remained unchanged, and no correlation 
between time and either the electrolyte concentrations or the saline osmolarities was 
observed. These results were not unexpected. First, diffusion through silicone is best 
accomplished by uncharged, hydrophobic molecules[23]. Electrolytes should therefore 
diffuse through the silicone wall sparingly, if at all. Corroborating evidence can be 
found in the experiments of Birnbaum, whose group, as previously mentioned, 
observed diffusion of only molecular iodine (L) through implants in vitro, with no 
change in the concentration of the charged, hydrophobic iodide fragment. Second, the 
lack of a correlation between time and the electrolyte concentrations further argues 
against diffusion. As exemplified visually by the lower portions of graphs 1 and 2, 
which show, respectively, the deviation of each sample's sodium and chloride 
concentration from the mean concentrations of these ions in the control saline, there is 
no pattern to the variations from the control means; for both electrolytes, the number of 
samples with concentrations exceeding the mean control concentration is nearly equal 
to the number of samples with concentrations less than the mean control 
concentrations. The results of the linear correlation analysis are confirmed clearly in 
graph 5, in which the sodium and chloride concentrations are plainly seen to be 
independent of time. When considered against a backdrop of no difference between the 
average sodium and chloride concentrations between the expanders and controls, these 
observations provide strong evidence against sodium and chloride diffusion into or out 
of the expanders. 
Potassium and bicarbonate present a less clear picture. Admittedly, the concentrations 
and deviations of potassium and bicarbonate shown in graphs 3 and 4, respectively, 
reveal elevations in the potassium and bicarbonate concentrations above the controls at 
nearly all time periods. Nevertheless, both a visual inspection of graph 6 and the 
formal correlation analysis show no linear relationship between either of these 
electrolytes' concentrations and time. That the pooled average concentrations of these 
electrolytes differ significantly between the expanders and controls implies either the 
existence of a diffusion process not conforming to (or even approximating) a linear 
relationship or the introduction of these electrolytes into the expander lumen in some 
other manner. The former explanation seems possible at first glance if one compares 
the potassium and bicarbonate concentrations within the control saline to their 
concentrations in rat plasma and interstitial fluid. As table 3 shows, the potassium and 
bicarbonate concentrations in the control saline are 1000 and 100 times less, 
respectively, than those in the extracellular fluid. A concentration gradient definitely 
exists. Furthermore, Fick's first law of diffusion states that in an ideal solution the 
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instantaneous rate of diffusion of a substance Q across a surface of area A is directly 
proportional to the concentration gradient of the substance across the surface (i.e., Com- 
Cin), the area A of the surface, and the diffusion coefficient D; it is inversely 
proportional to the distance L of diffusion (i.e., the thickness of the membrane). 
Mathematically, dQ/dt = DA/L(Cout-Cin) inmol/s[24]. Considering that the 
extracellular fluid and the plasma of the vascular space with which it is in equilibrium 
are together a much greater volume than the expander and are subject to homeostatic 
regulation, we may assume the concentrations of electrolytes outside the expander to be 
constant, i.e., Com is constant. To further simplify matters, given the magnitude of the 
difference between the concentrations of sodium and bicarbonate in the control saline 
and the extracellular fluid, we may assume their initial concentrations inside the 
expanders to be zero. It is important to note that this last assumption is unnecessary 
for the analysis and, indeed, would be inappropriate in the construction of a similar 
argument for sodium or chloride; it does, however, eliminate a constant and thereby 
simplifies the form of the final equation. Last, because we observed no change in the 
expander volumes during the experiment, we note that the quantity Q in moles of an 
electrolyte inside the expander is equal to the constant volume V of the expander times 
the electrolyte's concentration within the expander at that instant: Q = CmV. 
Substituting for Q and combining the constants D, A, L, and V into one large constant 
K, we obtain dCin/dt = K(Cout-Cin). Integrating this equation yields an expression 
relating the electrolyte's concentration within the expander to time: Cin = Com (l-e'kt), 
where k is a constant whose inverse is the time required for the concentration within 
the expander to rise to 63% (1-1/e) of Com.. This equation thus predicts that the 
concentration within the expander should not grow linearly but rather should increase 
at a decreasing rate, asymptotically approaching a concentration equal to Com. in much 
the same way as charge builds on a capacitor. Examination of graph 6, however, 
reveals no clear indication of such growth nor does it demonstrate the potassium or 
bicarbonate concentrations within the expanders asymptotically approaching their 
concentrations in the extracellular fluid. It could be argued that the bicarbonate graph 
resembles the theoretically predicted curve; to do so, however, not only ignores the 
fact that it appears to plateau at a concentration of approximately 0.80 mEq/L (versus 
the plasma value of 24 mEq/L) but also implies that there has been a rapid increase in 
the bicarbonate concentration from days 44 to days 47 and 48. Inspection of graph 4 
highlights the dubious nature of the bicarbonate value at day 44 (sample 2); indeed, 
when compared to the overall mean bicarbonate concentration, it deviates by more than 
two standard deviations (see table 1) and may thus be discarded. In doing so, the 
bicarbonate curve of graph 6 loses its resemblance to the theoretically predicted shape 
and instead closely resembles the curves of the other electrolytes, while at the same 
time virtually no changes in the results of the linear correlation analysis for bicarbonate 
occur (see following comparison table). 
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Original analysis with 
all samples 
Bicarbonate Analysis excluding 
sample 2 
Bicarbonate 
r2 0.41 r2 0.38 
r 0.64 r 0.62 
t5 1.87 t4 1.57 
t(0.05,5,2) 2.57 t(0.05,4,2) 2.77 
Given the above arguments, it appears that potassium and bicarbonate, like sodium and 
chloride, did not diffuse into the expanders during this experiment. The differences 
between the expanders and controls must be accounted for in some other manner. 
The most likely explanation for the elevations in potassium and bicarbonate is that at 
some steps in the experiment, systematic errors introduced these electrolytes into the 
saline of the expanders. An examination of table 5 reveals the difference between the 
average concentrations of potassium in the expanders and controls to be 0.0081 mEq/L. 
In the 20 mL volume of an expander this concentration difference corresponds to an 
increase of 0.000162 mEq potassium. Assuming an extracellular potassium 
concentration of 5.82 mEq/L, the introduction of a volume of only 0.028 mL (28 pL) 
of extracellular fluid into the expander could account for this difference. A similar 
calculation for bicarbonate indicates that 0.267 mL (267 pL) of extracellular fluid 
would be sufficient to account for the observed difference of 0.32 mEq/L between the 
average bicarbonate concentrations in the expanders and controls. One possible step in 
which such contamination could easily have occurred is the second injection of saline, 
which took place while the expander was already positioned within the subcutaneous 
pocket of the animal. Interstitial fluid could have been inadvertently injected into the 
expanders at this step, thus elevating the concentrations of all the electrolytes studied 
but being significant only for potassium and bicarbonate. It is interesting to note that 
sample 2, removed after 44 days, had a sharply decreased bicarbonate concentration. 
This expander was the only one in which infection was observed. The most probable 
explanation is that at implantation the offending bacteria were not only inoculated into 
the subcutaneous pocket but were also inoculated into the expander lumen, thus 
generating organic acids within the saline of the expander. Finally, possible 
contamination at the commercial laboratory can not be ruled out. 
In addition to the electrolyte concentrations, the volumes of the expanders and their 
final osmolarities were assessed for changes that may have occurred as the expanders, 
situated subcutaneously, were bathed in the interstitial fluid. Given the negligible 
amounts of potassium and bicarbonate in the samples, saline osmolarity was computed 
as [Na+] + [CL]. Plasma osmolarity was calculated as 2[Na+] + BUN/2.8 
+glucose/18[25]. Table 5 reveals no major differences between the expander and 
control saline osmolarities or between the expander saline and the extracellular fluid. 
The earlier discussion of Austad and Rose's self-inflating expander explained the 
requirement that the saline within the expander be not only hypertonic but also 
saturated with sodium chloride in order for maximal inflation to occur. The virtual 
isotonicity of the expander saline precludes its exerting any significant osmotic force 
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across the silicone membrane, and thus no changes in volume or osmolarity were 
observed. 
Like any experiment, this study has its inherent limitations. Perhaps the most 
significant is its limited sample size and relatively short observation period. A more 
sophisticated study might employ a far larger number of animals and follow them for a 
year. Such an experiment could thus measure multiple samples at each time period, 
obtaining a more complete picture of the changes in the expander saline over time. 
Obviously, such an experiment would be considerably more expensive than this one. 
Some reduction in cost could perhaps be achieved by using a permanent subcutaneous 
or external sampling port, thereby enabling minute samples of expander saline to be 
withdrawn at fixed time intervals. This technique would eliminate the need to sacrifice 
the animals in order to evaluate the expander contents and would thus reduce the 
number of animals and expanders needed. It would, however, increase the risk of 
bacterial infection and raise other avenues of potential contamination. Regardless of 
the technique used, a larger study would better address some questions which remain 
unresolved. For example, the possibility that diffusion occurred and ceased before the 
first expander was analyzed (sample 2, 44 days) can not be absolutely ruled out. The 
best argument against such an occurrence in this study is the failure of any electrolyte 
to have reached a mean concentration that is both significantly different from the 
control saline and close to the value found in rat plasma. More samples at earlier times 
would answer this question. It would also permit, by virtue of a wider range of time 
points, a more formal correlation analysis. This study employed a linear correlation 
analysis, a simplification whose use is based on the observation from the graphs that, 
over the relatively narrow range of times studied, the best fit curve would approximate 
a straight line. Since the correct equation, Cin = Corn (l-e~kt), is not linear in k, a 
better approach would employ a nonlinear fitting method such as a gradient-expansion 
algorithm (the Marquardt method) to fit the data to the predicted equation and evaluate 
the goodness of fit. Such an analysis, useless on the small data set of this experiment, 
would with a larger set of data be the most rigorous assessment of a diffusion process. 
If diffusion were present, it would also allow determination of the rate constant k for 
each electrolyte. 
Finally, the large numbers of saline implants and expanders already in patients could be 
the source of a future study. For instance, patients requiring implant removal for 
capsular contracture or cancer, or electively for further cosmetic enhancements, could 
have their implants analyzed, not only for saline composition but also silicone break 
down products, expander degradation, etc. Ideally, such studies would confirm the 
conclusions of this experiment, namely, that the saline within silicone shelled 
expanders and implants remains unchanged over time, and also answer any lingering 
questions concerning implant and expander safety. By evaluating these devices through 
studies in animals and humans, definitive characterization of their behavior in living 
organisms can be accomplished. This experiment hopefully is a first step in such an 
endeavor. 
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Figure 1. The tissue expanders used in the experiment 
Figure 2. Rat with implant 3 weeks postoperatively 
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Figure 4. Fibrous capsule surrounding tissue expander 
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